Author:
Roudsari Peyvand Parhizkar,Alavi-Moghadam Sepideh,Aghayan Hamid Reza,Arjmand Rasta,Gilany Kambiz,Rezaei-Tavirani Mostafa,Arjmand Babak
Reference36 articles.
1. Aghayan HR, Payab M, Mohamadi-Jahani F et al (2021) GMP-compliant production of human placenta-derived mesenchymal stem cells. Stem Cells and Good Manufacturing practices: Methods, Protocols, and Regulations:213–225
2. Alavi-Moghadam S, Sarvari M, Goodarzi P et al (2020) The importance of cleanroom facility in manufacturing biomedical products. Biomedical Product Development: Bench to Bedside:69–79
3. Albinger N, Hartmann J, Ullrich E (2021) Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany. Gene Ther 28(9):513–527. https://doi.org/10.1038/s41434-021-00246-w
4. Arjmand B, Alavi-Moghadam S, Parhizkar Roudsari P et al (2021) COVID-19 pathology on various organs and regenerative medicine and stem cell-based interventions. Front Cell Dev Biol 9:675310
5. Arjmand B, Alavi-Moghadam S, Rezaei-Tavirani M et al (2022) GMP-compliant mesenchymal stem cell-derived exosomes for cell-free therapy in cancer. In: Springer